User Stats

Total reviews: 1
Level: Guru
Member Since: 23/03/2023

Profile Information

First name John
Last name DE VOS
I have professional experience in:

Biotech, Therapeutics

Help us confirm that you're an expert

I’m Professor of Embryology and Histology at the Faculty of Medicine, University of Montpellier, and Head of the Department of Cell and Tissue Engineering, University Hospital of Montpellier. I was trained in human embryonic stem cells culture and derivation in Pr Josef Itskovitz-Eldor laboratory at the Stem cell Research Center, Technion-Israel Institute of Technology (Haifa, Israel) in 2004 and in the Laboratory of Pr. Outi Hovatta, Karolinska Institute, Stockholm, Sweden in 2006. My research, at the Institute for Research for Biotherapy (IRMB/INSERM U1183), is focused on human pluripotent stem cells, either embryonic stem cells or reprogrammed/iPS cells. My main research topics are safety and genetic integrity of pluripotent stem cells, and their potential to differentiate into bronchial epithelium cells. I model respiratory diseases using human iPSC-derived bronchial epithelium at air/liquid interface (iALI) and CRISPR/Cas9 technology, focusing on primary ciliary dyskinesia and the development of new treatments for this group or diseases.

How did you hear about us?

Goliver

Base
Name

John DE VOS

I have professional experience in:

Biotech, Therapeutics

Help us confirm that you're an expert

I’m Professor of Embryology and Histology at the Faculty of Medicine, University of Montpellier, and Head of the Department of Cell and Tissue Engineering, University Hospital of Montpellier. I was trained in human embryonic stem cells culture and derivation in Pr Josef Itskovitz-Eldor laboratory at the Stem cell Research Center, Technion-Israel Institute of Technology (Haifa, Israel) in 2004 and in the Laboratory of Pr. Outi Hovatta, Karolinska Institute, Stockholm, Sweden in 2006. My research, at the Institute for Research for Biotherapy (IRMB/INSERM U1183), is focused on human pluripotent stem cells, either embryonic stem cells or reprogrammed/iPS cells. My main research topics are safety and genetic integrity of pluripotent stem cells, and their potential to differentiate into bronchial epithelium cells. I model respiratory diseases using human iPSC-derived bronchial epithelium at air/liquid interface (iALI) and CRISPR/Cas9 technology, focusing on primary ciliary dyskinesia and the development of new treatments for this group or diseases.

LinkedIn

http://www.linkedin.com/in/john-de-vos-26452713

How did you hear about us?

Goliver